Last reviewed · How we verify
Treatment of adult smokers to help them stop smoking — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Chantix | Varenicline Tartrate | Pfizer Inc. | Nicotinic receptor partial agonist | α4β2 neuronal nicotinic acetylcholine receptors |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer Inc. · 1 drug in Treatment of adult smokers to help them stop smoking
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Treatment of adult smokers to help them stop smoking:
- Treatment of adult smokers to help them stop smoking treatment updates — RSS
- Treatment of adult smokers to help them stop smoking treatment updates — Atom
- Treatment of adult smokers to help them stop smoking treatment updates — JSON
Cite this brief
Drug Landscape (2026). Treatment of adult smokers to help them stop smoking — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-adult-smokers-to-help-them-stop-smoking. Accessed 2026-06-10.
Related
- Treatment of adult smokers to help them stop smoking full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing